Business Context and Reporting Period
This Form 8-K was filed by MEI Pharma, Inc. (not Lite Strategy, Inc.) on March 29, 2013. The report discloses executive compensation awards approved by the Compensation Committee under the Company's Amended and Restated 2008 Stock Omnibus Equity Compensation Plan.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. The only financial data disclosed relates to equity compensation terms:
- CEO Award: 400,000 Restricted Stock Units (RSUs) granted to Daniel P. Gold, PhD.
- CFO Award: 81,835 non-qualified stock options granted to Thomas M. Zech.
- CMO Award: 68,330 non-qualified stock options granted to Robert D. Mass.
- Option Exercise Price: $8.63 per share for the CFO and CMO awards.
Material Changes
The filing details a material change in executive compensation structure intended to offset dilution from a December 2012 private placement of Common Stock and warrants. No other material changes to operations or financial status are reported in this document.
Guidance, Outlook, and Risks
Management commentary indicates the awards were designed to align executive interests with stockholders and retain leadership for long-term development initiatives. The filing does not contain forward-looking financial guidance, specific risk factors, or contingencies beyond the standard vesting conditions.
Vesting Schedule:
- CEO RSUs: One-third vests annually on August 30, 2014, 2015, and 2016. Delivery occurs on the earliest of the fifth anniversary of the grant date, death/disability/separation, or a change in control.
- CFO/CMO Options: One-quarter vests on March 29, 2014, with the remainder vesting in equal monthly installments over the following 36 months.
Investor Verification Checklist
- Verify the impact of the December 2012 private placement on existing shareholder dilution.
- Confirm the current market price of MEI Pharma stock relative to the $8.63 option exercise price.
- Review the full terms of the Amended and Restated 2008 Stock Omnibus Equity Compensation Plan.
- Check for subsequent filings regarding the vesting status of these awards.